Industry News - Medika Life

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

VIVE 2023 Made Several Wise Decisions in Coming To Nashville

Gil Bashe, Medika Life Editor - March 27, 2023

ViVE2023, CHIME and Start Up Health Kick off a Four-Day Health Lollapalooza

FDA Approves Drug Combination for Treating Mesothelioma

Medika Life - October 5, 2020

First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

At HLTH Europe, Briya Opens No-Cost Access to AI-Powered Research

Health AI Faces a Human Test

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Health Innovation Has a Friction Problem

LATEST

TRENDING

Reiner Fuellmich Fact Checked and Exposed as a Covid Conspiracy Con

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

We Call Out Reiner Fuellmich as a Fraud. The Covid Conspirator Investigated

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Worshiping at The Alter of Zach Bush’s Messianic Health Cult

Exposing America’s Frontline Doctors and Their Financial Empire Built on Hydroxychloroquine

Who Not To Trust: A List of 10 Covid-19 Charlatans and “Medical” Snake-Oil Salesmen

The Medika Life Top 30 Voices Transforming Wellness for 2022/23

Medika’s Top 20 AI Voices to Watch. Follow These Experts as They Demystify AI and Its Future

The Medika Life 50 – The Most Influential Voices in Health for 2022

EDITORS CHOICE

Monoclonal Antibody Infusions. The Plan B Emergency Contraception for Covid?

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

VIVE 2023 Made Several Wise Decisions in Coming To Nashville

FDA Approves Drug Combination for Treating Mesothelioma

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories